(Workshop Presentation) Learn the ins and outs of cannabis cultivation from seasoned operator Alex Cooley of Solstice. Gain understanding of the process and practices from selecting a site to creating a finished product. Unique format that takes you through the steps but significantly engages audience members via an AMA format.
(Panel Discussion) One worker’s medicine is another’s asthma attack. And regulatory loosening of marijuana will almost certainly cause a paradigm shift from pee-in-a-cup disciplinary programs to accommodation on medical grounds. Everything from human rights laws to workplace safety regulations to common courtesy will be in play as employers and employees seek common ground on all new territory. This panel will identify and sort out some of the biggest issues. Moderator: Lorenzo Lisi, Partner, Aird & Berlis LLP, Canada
(Presentation) Jonathan and Joan will speak about the potential implications legalization will have for patients as well as their service providers. This session will cover areas including access, affordability, cost coverage, and research.
(Panel Discussion) The full legalization of cannabis in Canada puts this country and its industry on a very different path from the U.S., given that there are many states along with the U.S. federal government that still criminalize its possession. And while there are growing opportunities for bilateral trade between Canada and other countries, considerable challenges remain in creating an international market. What are the differences and similarities between the regulatory regimes of both countries as well as elsewhere in the world, and the challenges these represent that would affect cannabis producers and distributors who are seeking partnerships and cross-border investment? What impact does full legalization have for producers seeking new avenues for export and [...]
(Panel Discussion) Whatever framework the marijuana industry adopts in Canada, it won’t be as simple or as cheap as planting seeds and harvesting plants. There will be cost drivers in bringing the product to market, regulatory requirements, intellectual property issues, licenses and standards. Pricing structures will be pushed up by costs and pushed down by competition. This session will take a cold, hard look at the return-on-investment to be expected in the new weed order. Moderator: Deepak Anand, Executive Director, MBA, Canadian National Medical Marijuana Assoc. Presented by: Kwantlen Polytechnic University (KPU)
(Presentation) Due to the complex structure of the different cannabinoids and terpenes profiles varying from strains-to-strain, cannabis researchers and scientist are only now just scratching the surface in efforts to treat and even cure serious illness. The antidotal data is staggering in contrast to the underfunded anecdotal evidence pales in comparison. One thing is certain that when cannabis is grown in a clean, consistent, and stabilized environment it is optimal for scientific research, as well as patient consistency. We will talk about the optimal environmental parameters in which cannabis is grown and how indoor grow facilities are constructed with the overall the goal to minimize the introduction, generation, and retention of airborne particulates, and pest [...]
(Panel Discussion) This interactive panel discussion will focus on the importance of cannabis testing and the need for unified methods and testing standards. You will hear from Tracy Ryan of CannaKids who will speak to the need for medical cannabis products to be free of contaminants and for accurate cannabinoid dosing and potency labeling when dealing with pediatric and adult patients. Robert Clifford, PhD will discuss the different analytical instrumentation used for cannabis testing. Douglas Rennie will discuss the need for agreement in unified methods and standards associated with cannabis testing, as well as share his insights on past and current efforts by the AOCS in the development of unified methods and standards in a [...]
(Presentation) Join Gordon for a candid and informative talk on the real world of cannabis laboratory testing and it's impact on the industry. He will explore subjects from pseudo testing, lab economics, client interaction, the regulatory role, consumer safety and predictions of what may be around the corner as the industry matures.
Expanding the Frontier of Cannabis Genetics: Unique Approaches to Phenotypic Analysis/Genetic Markers
(Presentation) A presentation on the cannabis marker assisted breeding program, the first of its kind in the cannabis Industry.
(Presentation) The emerging field of cannabinoid medicine is similar to the field of neuroscience or personalized medicine, where new advancements in diagnostics, software, and treatments have changed the way medicine is practiced. Yet cannabis research in the United States and other countries is restricted by numerous legal, financial, and social stigma hurdles due to its placement as Schedule IV of the Single Convention on Narcotic Drugs. An overview of cannabis research past, present and future will highlight how much yet how little we know. Strategies to obtain funding and approval for cannabis research, methods to standardize data collection and analysis, publication opportunities, and product development pipelines will be reviewed. Opportunities to collaborate on research, share [...]